Drug Shortage Report for DALACIN C PHOSPHATE

Last updated on 2021-02-17 History
Report ID 134283
Drug Identification Number 00260436
Brand name DALACIN C PHOSPHATE
Common or Proper name Dalacin C Phosphate
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 25x6mL vial
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-12-31
Actual start date
Estimated end date 2022-04-01
Actual end date
Shortage status Anticipated shortage
Updated date 2021-02-17
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-17 French Compare
v1 2021-02-17 English Compare